# Leaps by Bayer

Source: https://onco.cc/companies/leaps-by-bayer/  
OnCo record `leaps-by-bayer` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Bayer's impact investing unit, which funds companies tackling ten 'leaps' in health and agriculture, including curing cancer. Its website blocked automated access at the time of research.

## Summary

Leaps by Bayer is the impact investment unit of Bayer AG that backs early-stage companies pursuing large 'leaps' in health and agriculture; one of its stated leaps concerns cancer, and it has invested in cell therapy and precision oncology start-ups. Its website (leaps.bayer.com) and the Leaps page on bayer.com both returned HTTP 403 with a 'Site Maintenance' bot-blocking message on every attempt, so the unit's own description, founding year, location and named oncology portfolio companies could not be confirmed from a primary source.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: corporate-venture
- HQ: Berlin
- Type: investor
- Website: https://leaps.bayer.com/

## Notes

- Website could not be fetched by the research pass on 2026-09-10 (bot protection, JavaScript-only or parked domain); location and description rest on the firm's public materials and on press releases that name it. leaps.bayer.com and bayer.com returned 403 bot-block pages via curl and WebFetch. Berlin follows the task hint (Bayer's pharmaceuticals division is based in Berlin; the group HQ is Leverkusen).

## Sources

- Official website: https://leaps.bayer.com/

## Connected records

- companies: [Affini-T Therapeutics](https://onco.cc/companies/affini-t-therapeutics/), [Bayer](https://onco.cc/companies/bayer/), [Century Therapeutics](https://onco.cc/companies/century-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/leaps-by-bayer.json